Topadur Pharma AG
🇨🇭Switzerland
- Country
- 🇨🇭Switzerland
- Ownership
- Holding
- Established
- 2015-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.topadur.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Safety and Tolerability of TOP-N53 Applied on Digital Ulcers in Patients With Systemic Sclerosis
Phase 2
Recruiting
- Conditions
- Digital Ulcers in Systemic Sclerosis
- Interventions
- First Posted Date
- 2025-05-01
- Last Posted Date
- 2025-09-30
- Lead Sponsor
- Topadur Pharma AG
- Target Recruit Count
- 15
- Registration Number
- NCT06954597
- Locations
- 🇫🇷
CHU Grenoble Alpes, La Tronche, France
🇫🇷AP-HP Hôpital Cochin, Paris, France
News
No news found